Tech Company Financing Transactions
Pipeline Therapeutics Funding Round
Pipeline Therapeutics closed a $80 million Series C venture capital round on 2/12/2021. Investors included Brace Pharma, Casdin Capital and Franklin Templeton.
Transaction Overview
Company Name
Announced On
2/12/2021
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Series C
Investors
Proceeds Purpose
Pipeline Therapeutics plans to use the proceeds to advance its development candidates PIPE-505, in patients with sensorineural hearing loss, and PIPE-307, in patients with multiple sclerosis.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10578 Science Center Dr. 200
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Pipeline Therapeutics is a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carmine Stengone
Chief Financial Officer
Peter Slover
Chief Marketing Officer
Stephen Huhn
Chief Scientific Officer
Daniel Lorrain
Vice President
Jon Seiders
VP - Operations
Julie Iwashita
VP - R & D
Austin Chen
Browse more venture capital transactions:
Prev: 2/12/2021: Personal Genome Diagnostics venture capital transaction
Next: 2/12/2021: Compute North venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records on this site are derived from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs